AbsEn.i
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (France)

Index « AbsEn.i » - entrée « severe »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
several < severe < severely  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 58.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000006 (2020) Thomas Maldiney [France] ; Clémence Deschasse [France] ; Philip Bielefeld [France]Tocilizumab for the Management of Corticosteroid-Resistant Mild to Severe Graves' Ophthalmopathy, a Report of Three Cases.
000017 (2020) Gonzalo De Luna [France] ; Anoosha Habibi [France] ; Jean François Deux [France] ; Martin Colard [France] ; Anne Laure Pham Hung D'Alexandry D'Orengiani [France] ; Frédéric Schlemmer [France] ; Nizar Joher [France] ; Christian Kassasseya [France] ; Jean Michel Pawlotsky [France] ; Clément Ourghanlian [France] ; Marc Michel [France] ; Armand Mekontso-Dessap [France] ; Pablo Bartolucci [France]Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab.
000021 (2020) Giacomo Bellani [Italie] ; Tài Pham [France] ; John G. Laffey [Irlande (pays)]Missed or delayed diagnosis of ARDS: a common and serious problem
000038 (2020) Salah Ghabri [France] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Franck Maunoury [France] ; J Jaime Caro [États-Unis]Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France.
000041 (2020) Robert David Sandler [Royaume-Uni] ; Rachel Scarlett Tattersall [Royaume-Uni] ; Helene Schoemans [Belgique] ; Raffaella Greco [Italie] ; Manuela Badoglio [France] ; Myriam Labopin [France] ; Tobias Alexander [Allemagne] ; Kirill Kirgizov [Russie] ; Montserrat Rovira [Espagne] ; Muhammad Saif [Royaume-Uni] ; Riccardo Saccardi [Italie] ; Julio Delgado [Espagne] ; Zinaida Peric [Croatie] ; Christian Koenecke [Allemagne] ; Olaf Penack [Allemagne] ; Grzegorz Basak [Pologne] ; John Andrew Snowden [Royaume-Uni]Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)
000044 (2020) Florence A. Aeschlimann [France, Suisse] ; Marinka Twilt [Canada] ; Rae S. M. Yeung [Canada]Childhood-onset Takayasu Arteritis
000052 (2019-06-12) Alain Saraux [France] ; Thomas Barnetche [France] ; Guy Baudens [France] ; Isabelle Idier [France] ; Flore Delaporte [France] ; Pascal Hilliquin [France]Subcutaneous tocilizumab in monotherapy or in combination with csdmard in patients with moderate to severe rheumatoid arthritis: observational study to describe real-world drug retention rate at 12 months.
000066 (2019) Emmanuel Andrès [France] ; Noel Lorenzo Villalba [France] ; Abrar-Ahmad Zulfiqar [France] ; Khalid Serraj [Maroc] ; Rachel Mourot-Cottet [France] ; Jacques-Eric Gottenberg [France]State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies
000078 (2019) Marc Humbert [France] ; Christophe Guignabert [France] ; Sébastien Bonnet [Canada] ; Peter Dorfmüller [France] ; James R. Klinger [États-Unis] ; Mark R. Nicolls [États-Unis] ; Andrea J. Olschewski [Autriche] ; Soni S. Pullamsetti [Allemagne] ; Ralph T. Schermuly [Allemagne] ; Kurt R. Stenmark [États-Unis] ; Marlene Rabinovitch [États-Unis]Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
000091 (2019) Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France]Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
000096 (2019) Mélanie Rinaudo-Gaujous ; Vincent Blasco-Baque ; Pierre Miossec ; Philippe Gaudin ; Pierre Farge ; Xavier Roblin ; Thierry Thomas [France] ; Stephane Paul ; Hubert Marotte [France]Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis Patients
000098 (2019) Yann Nguyen [France] ; Carine Salliot [France] ; Gaëlle Gusto [France] ; Elise Descamps [France] ; Xavier Mariette [France] ; Marie-Christine Boutron-Ruault [France] ; Raphaèle Seror [France]Improving accuracy of self-reported diagnoses of rheumatoid arthritis in the French prospective E3N-EPIC cohort: a validation study
000106 (2019) Marianna Parlato [France] ; Fabienne Charbit-Henrion [France] ; Abi Nader Elie [France] ; Bernadette Begue [France] ; Nicolas Guegan [France] ; Julie Bruneau [France] ; Shérine Khater [France] ; Elizabeth Macintyre [France] ; Capucine Picard [France] ; Rieux-Laucat Frédéric [France] ; Lionel Le Bourhis [France] ; Matthieu Allez [France] ; Olivier Goulet [France] ; Christophe Cellier [France] ; Olivier Hermine [France] ; Nadine Cerf-Bensussan [France] ; Georgia Malamut [France]Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation
000110 (2019) Noemi Muszbek [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Marie Fournier [France] ; Chieh-I Chen [États-Unis] ; Andreas Kuznik [États-Unis] ; Zsofia Kiss [Royaume-Uni] ; Peter Gal [Hongrie] ; Kaleb Michaud [États-Unis]Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs
000133 (2018-10-19) P. Hilliquin [France] ; T. Barnetche [France] ; G. Baudens [France] ; R. Niarra [France] ; I. Idier [France] ; A. Saraux [France]Subcutaneous Tocilizumab in Monotherapy or in Combination with DMARD in Patients with Moderate to Severe Active Rheumatoid Arthritis: Observational Study to Describe Real-World Drug Retention Rate at 12 Months, Interim Analysis
000152 (2018) Niloufar Kavian [France] ; Souad Mehlal [France] ; Mohamed Jeljeli [France] ; Nathaniel Edward Bennett Saidu [France] ; Carole Nicco [France] ; Olivier Cerles [France] ; Sandrine Chouzenoux [France] ; Anne Cauvet [France] ; Claire Camus [France] ; Mehdi Ait-Djoudi [France] ; Christiane Chéreau [France] ; Saadia Kerdine-Römer [France] ; Yannick Allanore [France] ; Frederic Batteux [France]The Nrf2-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma
000166 (2018) Fernando Kemta Lekpa [Cameroun] ; Xavier Chevalier [France]Refractory relapsing polychondritis: challenges and solutions
000176 (2018) Eugen Feist [Allemagne] ; Stéphane Mitrovic [France] ; Bruno Fautrel [France]Mechanisms, biomarkers and targets for adult-onset Still’s disease
000182 (2018) Mélanie Lambert [France] ; Véronique Capuano [France] ; Andrea Olschewski [Autriche] ; Jessica Sabourin ; Chandran Nagaraj ; Barbara Girerd [France] ; Jason Weatherald [France, Canada] ; Marc Humbert [France] ; Fabrice Antigny [France]Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?
000190 (2018) Cem Gabay [Suisse] ; Jérôme Msihid [France] ; Moshe Zilberstein [États-Unis] ; Caroline Paccard [France] ; Yong Lin [États-Unis] ; Neil M H. Graham [États-Unis] ; Anita Boyapati [États-Unis]Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET study
000215 (2018) Alice Horisberger [Suisse] ; Stefano La Rosa [Suisse] ; Jean-Philippe Zurcher [Suisse] ; Stefan Zimmermann [Suisse] ; Francois Spertini [Suisse] ; George Coukos [Suisse] ; Michel Obeid [Suisse, France]A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i -k "severe" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i  \
                -Sk "severe" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    severe
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021